Evidence map›Paper›PMID 35675816›Full record

ArticlePolish journal of microbiology2022

Prevalence and Drug Resistance Pattern of

Khairallah A S Mohammed, Ghorob S Khudhair, Dheyaa Bekheet Al-Rabeai

Open access · goldAbstract read
In one paragraph

Article in Polish journal of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Comparison of characteristics of drug-resistantJournal of family medicine and primary care · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Rifampicin-resistantJournal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Khairallah A S MohammedDepartment of Medical Lab Technology, College of Health and Medical Technology, Southern Technical University, Basra, Iraq.ORCID https://orcid.org/0000-0002-1175-0996
Ghorob S KhudhairDepartment of Medical Lab Technology, College of Health and Medical Technology, Southern Technical University, Basra, Iraq.
Dheyaa Bekheet Al-RabeaiAdvisory Clinic for Chest Diseases and Respiratory, Basra, Iraq.
Southern Technical University · IQUniversity of Basrah · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-resistant

Indexed as

Mycobacterium tuberculosisTuberculosisTuberculosis, Multidrug-ResistantAdolescentAdultAntitubercular AgentsDrug Resistance, Multiple, BacterialEthambutolHumansIraqIsoniazidPrevalenceRifampinStreptomycinYoung AdultAntitubercular AgentsEthambutolIsoniazidRifampinStreptomycinBasradrug resistanceMDR-TBMycobacterium tuberculosisretreated TB

Identifiers

PMID35675816
PMCPMC9252138
OpenAlexW4282025237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.